About Celosia Pharmaceutical
Celosia Pharmaceutical is a Business Services company. Pharmaceutical products and consulting services in Chennai. It operates in the Business Services and Healthcare sectors. The company has 1 employees. Its Indian entity Celosia Pharmaceutical Private Limited reported revenue of ₹2.51 Cr. Celosia Pharmaceutical offers products and services including CLOCEONAC-TS and CELOGEN PLUS. Its focus areas include Consulting, Business Consulting, Innovation Services and Pharmaceuticals.
Company details
Celosia Pharmaceutical is headquartered in Chennai, Tamilnadu, where efforts are directed towards excellence in the consulting space through innovation and technology. The company provides pharmaceutical products such as analgesics and treatments for osteoarthritis, which are marketed for pain relief and joint health. A team is assembled to pursue business objectives, emphasizing product development and distribution. Operations are supported by various channels, including online platforms, and the focus remains on meeting industry standards without promotional intent. This approach ensures reliable offerings in healthcare solutions.
- Employees 1
- SectorsBusiness ServicesHealthcare
- Email••••••••
- Phone•••• ••••
- Legal Name Celosia Pharmaceutical Private Limited
- Date of Incorporation 26 May, 2016
- Jurisdiction Chennai, Tamil Nadu, India
- Indian entity revenue₹2.51 Cr
FY 2025 · +11% YoY
- Indian entity net profit₹1.5 Lakh
FY 2025 · 1% margin
- Indian entity EBITDA₹2.9 Lakh
FY 2025 · 1% margin
- Employee Count1
Associated legal entities of Celosia Pharmaceutical
Celosia Pharmaceutical operates through Celosia Pharmaceutical Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Celosia Pharmaceutical Private Limited CIN U74999TN2016PTC110591 | Active | 26 May 2016 | Chennai, Tamil Nadu | ₹2.5 Cr | 2 | View details |
Products & Services of Celosia Pharmaceutical
Celosia Pharmaceutical offers a comprehensive portfolio of products and services, including CLOCEONAC-TS and CELOGEN PLUS.
This tablet is used for relieving pain and swelling in conditions such as arthritis
This tablet is employed for the treatment of arthritis and osteoarthritis through various active ingredients
Board of directors of Celosia Pharmaceutical Private Limited (Celosia Pharmaceutical)
Celosia Pharmaceutical Private Limited is the primary company behind Celosia Pharmaceutical. The board of Celosia Pharmaceutical Private Limited currently have 2 directors; the longest-serving is Ajay Kumar Srivastava, appointed in 2016. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ajay Kumar Srivastava DIN 06611954 | Director | 26 May 2016 | 10 yrs 5 mo | Celosia Pharmaceutical Private Limited |
| Asha Srivastava DIN 08301293 | Additional Director | 11 Dec 2018 | 7 yrs 10 mo | Celosia Pharmaceutical Private Limited |
Financials of Celosia Pharmaceutical
Figures of Celosia Pharmaceutical Private Limited, the primary company behind Celosia Pharmaceutical, for FY 2025. Revenue was ₹2.51 Cr (+11% year on year). Net profit was ₹1.5 Lakh (1% margin). EBITDA was ₹2.9 Lakh (1% margin). Revenue has grown at a compounded annual rate of +18% over three years and +13% over five years.
- ₹2.51 CrRevenue · FY 2025 · +11% YoY
- ₹1.5 LakhNet profit · 1% margin
- ₹2.9 LakhEBITDA · 1% margin
- ₹10 LakhPaid-up capital
- +18%Revenue CAGR, 3 years
- +13%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Celosia Pharmaceutical Private Limited are on its company page.
Detailed financial statements for Celosia Pharmaceutical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Celosia Pharmaceutical
Celosia Pharmaceutical has 1 employees.
The primary company behind Celosia Pharmaceutical, Celosia Pharmaceutical Private Limited, reported revenue of ₹2.51 Cr for FY 2025, up 11% year on year.
Celosia Pharmaceutical is headquartered in Chennai, Tamilnadu, where efforts are directed towards excellence in the consulting space through innovation and technology. The company provides pharmaceutical products such as analgesics and treatments for osteoarthritis, which are marketed for pain relief and joint health. A team is assembled to pursue business objectives, emphasizing product development and distribution. Operations are supported by various channels, including online platforms, and the focus remains on meeting industry standards without promotional intent. This approach ensures reliable offerings in healthcare solutions.
Celosia Pharmaceutical offers CLOCEONAC-TS and CELOGEN PLUS.
Celosia Pharmaceutical operates through Celosia Pharmaceutical Private Limited.
The legal entities of Celosia Pharmaceutical currently have 2 directors, including Asha Srivastava, Ajay Kumar Srivastava.